Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?

BACKGROUND: Guidelines suggest that patients discontinue Clopidogrel at least 5 days prior to coronary artery bypass grafting (CABG). Those with acute coronary syndrome (ACS) are at high risk for myocardial infarction (MI) if not treated with dual antiplatelet therapy (DAPT). We sought to assess pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Charif, Fida, Hamdan, Righab, Youness, Genane, El Zein, Ali, Issa, Mohamad, Jassar, Yehya, Younes, Mahmoud, Saab, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880414/
https://www.ncbi.nlm.nih.gov/pubmed/31775803
http://dx.doi.org/10.1186/s13019-019-1028-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880414/
https://www.ncbi.nlm.nih.gov/pubmed/31775803
http://dx.doi.org/10.1186/s13019-019-1028-2

Ejemplares similares